Literature DB >> 22477621

Metabolic syndrome, peripheral vascular disease and coronary artery disease: A concise review.

Thomas F Whayne1.   

Abstract

Metabolic syndrome has a very strong association with both forms of cardiovascular (CV) disease - coronary artery disease and peripheral vascular disease. There is also a marked interrelationship between the two forms of CV disease. When one form of CV disease is present, the other should be strongly suspected and the possible occurrence of associated vascular events should be clinically evaluated. When three of the five major components that define metabolic syndrome are present, the clinical evidence indicates that one or both forms of CV disease are present, at least in incipient form. To give maximum clinical benefit to the patient at risk, the clinician must be aware of these associations, look for them and institute the measures that can reduce the risk of progression.

Entities:  

Year:  2010        PMID: 22477621      PMCID: PMC3014594          DOI: 10.1055/s-0031-1278376

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  29 in total

1.  World Health Organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40-49 years.

Authors:  Tomoko Takamiya; Wahid R Zaky; Daniel Edmundowics; Takashi Kadowaki; Hirotsugu Ueshima; Lewis H Kuller; Akira Sekikawa
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

2.  A cytokine-to-chemokine axis between T lymphocytes and keratinocytes can favor Th1 cell accumulation in chronic inflammatory skin diseases.

Authors:  C Albanesi; C Scarponi; S Sebastiani; A Cavani; M Federici; S Sozzani; G Girolomoni
Journal:  J Leukoc Biol       Date:  2001-10       Impact factor: 4.962

3.  ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure).

Authors:  S A Hunt; D W Baker; M H Chin; M P Cinquegrani; A M Feldman; G S Francis; T G Ganiats; S Goldstein; G Gregoratos; M L Jessup; R J Noble; M Packer; M A Silver; L W Stevenson; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; A K Jacobs; L F Hiratzka; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

4.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

5.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

6.  Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy.

Authors:  Stephen D Wiviott; Christopher P Cannon; David A Morrow; Kausik K Ray; Marc A Pfeffer; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2005-10-18       Impact factor: 24.094

7.  Relationship between peripheral arterial disease and metabolic syndrome.

Authors:  Milos Maksimovic; Hristina Vlajinac; Djordje Radak; Jelena Marinkovic; Jagoda Jorga
Journal:  Angiology       Date:  2009-01-14       Impact factor: 3.619

8.  Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.

Authors:  John K Ninomiya; Gilbert L'Italien; Michael H Criqui; Joanna L Whyte; Anthony Gamst; Roland S Chen
Journal:  Circulation       Date:  2003-12-15       Impact factor: 29.690

9.  Oxidative stress in metabolic syndrome.

Authors:  Praveen Sharma; Sandhya Mishra; Peeyush Ajmera; Sandeep Mathur
Journal:  Indian J Clin Biochem       Date:  2005-01

10.  Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Authors:  J Shepherd; S M Cobbe; I Ford; C G Isles; A R Lorimer; P W MacFarlane; J H McKillop; C J Packard
Journal:  N Engl J Med       Date:  1995-11-16       Impact factor: 91.245

View more
  3 in total

1.  Models for estimating the metabolic syndrome biological age as the new index for evaluation and management of metabolic syndrome.

Authors:  Young Gon Kang; Eunkyung Suh; Hyejin Chun; Sun-Hyun Kim; Deog Ki Kim; Chul-Young Bae
Journal:  Clin Interv Aging       Date:  2017-02-01       Impact factor: 4.458

2.  Peripheral and cognitive benefits of physical exercise in a mouse model of midlife metabolic syndrome.

Authors:  Farida El Gaamouch; Hsiao-Yun Lin; Qian Wang; Wei Zhao; Jiangping Pan; Kalena Liu; Jean Wong; Clark Wu; Chongzhen Yuan; Haoxiang Cheng; Weiping Qin; Ke Hao; Bin Zhang; Jun Wang
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.996

3.  The relationship between metabolic syndrome and increase of metabolic syndrome score and serum vitamin D levels in Korean adults: 2012 Korean National Health and Nutrition Examination Survey.

Authors:  Hyun Yoon; Gwang Seok Kim; Sung Gil Kim; Ae Eun Moon
Journal:  J Clin Biochem Nutr       Date:  2015-06-17       Impact factor: 3.114

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.